Platform Company
Unlocking the value of medical imaging
Quibim is a global healthtech company pioneering AI-powered imaging biomarkers for precision medicine.
We turn routine medical images — MRI, CT, and PET –, alongside molecular and clinical data into quantitative, actionable insights across oncology, neurology, immunology and metabolic diseases Through value-based partnerships with biopharma, we help drug developers identify the right patients, monitor response and accelerate their programs. Through regulated software-as-a-medical-device, we bring hospitals standardized, decision-ready evidence that supports more consistent and confident clinical decisions.
-
0 +sites working with Quibim products worldwide
-
0 K+de-identified cancer patients registry
-
0 M+de-identified research imaging dataset
-
0 +publications in high impact factor journals
-
0of the top 20 pharma companies working with us
-
0 +active clinical studies
End-to-end AI platform for precision medicine
QP-Insights®, our proprietary platform, is the engine beneath every product and partnership: one validated AI platform that carries imaging the whole way, from a biomarker in a scan to a regulatory-cleared product.
Built on Quibim’s proprietary datasets and foundational models, QP‑Insights® enables faster, more precise, and scalable insights to understand disease as never before , helping clinicians make more informed, patient‑centered decisions that improve outcomes and quality of care.
To translate research into clinical practice, Quibim combines its core platform with in-house quality and regulatory, commercial and market access expertise to take innovations through development, regulatory clearance, launch, and clinical adoption.
Inside QP-Insights®: Where Imaging Becomes Evidence
Radiomics is at the core of our platform :a technology that extracts detailed quantitative disease specific insights from routine medical images. QP-Insights® , Quibim’s proprietary platform, builds on this foundation to develop and validate AI models that support diagnosis, prognosis, and prediction of treatment response for more personalized care.
QP-Insights® carries imaging all the way to actionable evidence. The same platform connects image acquisition, quantitative analysis, model development, validation, and real-world application, bringing imaging insights to clinicians, researchers, and pharma teams.
Explore here our interactive infographic
QP-Insights® Cloud Infrastructure
A secure, cloud-based infrastructure built to bring imaging, multi-omics, and clinical data together.
QP-Insights® centralizes, manages, harmonizes, and processes medical imaging at scale, integrating AI-powered solutions and data workflows from image acquisition through analysis and reporting.
Fully web-based allowing centralization of imaging studies, multi-omics and clinical data:
- Ensures end‑to‑end data protection with encryption applied both at rest and in transit.
- Supports full de-identification of patient data
- Able to integrate with local PACS to enable automatic transfer of images and reports via QP-Link (Quibim’s connector)
- Manages, indexes, and stores multi-omics data
- Real-time data QC and radiological readings
- Fully automated quantification of imaging biomarkers
- Structured quantitative reports delivered directly to PACS
- Customizable based on user requirements
- ISO 27001 certified
- HIPAA and GDPR compliant
Read more about our legal & data security measures here.
